Skip to Main Content

Paper Details

NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants.
Mol Cancer Res
9
2021
Author NameAffiliation
Leigh EllisDana-Farber Cancer Institute, Harvard Medical School
Leigh EllisBrigham and Women's Hospital, Harvard Medical School
Leigh EllisThe Broad Institute
  • 1 - 3

Datasets

Release 1.2